Ranbaxy posts Rs 1.6 bn profit in last quarter

India's largest drug manufacturer Ranbaxy Laboratories announces a Net Profit of Rs 1.6 billion on a consolidated basis in the second quarter.

India's largest drug manufacturer Ranbaxy Laboratories announced on Tuesday a Net Profit of Rs 1.6 billion ($39 million) on a consolidated basis in the second quarter of this year ending June 30, exactly the same gain made in the comparable period last year. The firm starts its accounting year Jan 1.

HT Image

Total sales at Rs 18.3 billion ($440 million) in the quarter under review was up 13 per cent from Rs 16.2 billion ($395 millon) earned in the previous quarter.